Neue Suche | Kongressdetail
mail
Druckansicht
 
 

2nd Fc Receptor & IgG Targeted Therapies Summit

Evvnt Promotion / evvnt
-
26.04.2022 - 28.04.2022  Hilton Boston Back Bay, 40 Dalton Street, 02115 Boston, USA
Time: 9:00 AM - 4:00 PM
 
Kongressthemen
FcRn, Fcγ, and IgG studies have been propelled by drug developers recently after Argenx’s potential FDA’s approval of first-in-class FcRn antagonist efgartigimod, AstraZeneca-Alexion’s $39 billion deal, and positive clinical updates from UCB’s Rozanolixizumab. Successful modulation of the Fc pathways and optimized IgG antibodies have proven clinical utility and demonstrate significant therapeutic potential with more players poised to bring their candidates through clinic.
Kongressorganizer (PCO)
Hanson Wade
 

Anfragen und Anmeldung:

https://go.evvnt.com/972245-1?pid=4832
Frau Erin Thomas
 
Kategorien
Allgemeinmedizin
Sprache
Englisch
Kongressgebühr
Conference + 2 Workshops - Pharma Biotech USD 3897.00, Conference Only - Pharma Biotech USD 2999.00, Conference + 2 Workshops - Service provider USD 4697.00, Conference Only - Service provider USD 3599.00
Teilnehmer erwartet
1000
Veranstalter Kontakt
83 Great Titchfield Street
W1W 6RH London
Großbritannien
 
"GOING INTERNATIONAL fördert den Zugang zu Aus-, Fort- und Weiterbildung, unabhängig von sozialen, geographischen und nationalen Grenzen."

European Health Forum GasteinHelix - Forschung & Beratung WienSwiss Tropical and Public Health InstituteÖsterreichisches Rotes KreuzÄrzte der WeltHilfswerk AustriaCentro per la Formazione Permanente e l'Aggiornamento del Personale del Servizio SanitarioAGEM - Arbeitsgemeinschaft Ethnologie und Medizin